BL

Active Director Director DIN 09683390
DIN 09683390 First appointment Jul 2022 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Babu Lal

Data last updated:

Babu Lal is a Director at Surgimax Instruments Private Limited (since 2022). The company operates in Manufacturing. Surgimax Instruments Private Limited reported revenue of ₹75.9 Lakh (FY 2025).

DIN 09683390
Primary Designation Director
Industry Manufacturing
First Appointment 22 Jul 2022
Oldest Company Age 4 yrs
Largest company Surgimax Instruments Private Limited · ₹75.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Surgimax Instruments Private Limited U33203UP2022PTC168126
Director22 Jul 20222022₹75.9 Lakh (FY 2025)Active

Board colleagues of Babu Lal

Directorship timeline

Open interactive timeline →
Surgimax Instruments Private Limited
Premium access

Shareholding and investment profile for Babu Lal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babu Lal

Babu Lal currently holds 1 directorship: Surgimax Instruments Private Limited (Director, since 22 Jul 2022, revenue ₹75.9 Lakh (FY 2025)).

Babu Lal was first appointed on 22 Jul 2022 as Director at Surgimax Instruments Private Limited.

The current boards of Babu Lal's companies include Himanshu Srivastava (Surgimax Instruments Private Limited), Manglesh Chaudhry (Surgimax Instruments Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available